ADA Highlights

flipper_slider

Editor's Choice

Chantal Mathieu discusses the outcomes of the EMPA-REG, LEADER and SUSTAIN-6 trials on diabetes treatment. Part 1 of 2 View Part 2 here.

ADA Highlights Videos

James Foley and Bo Ahren review the development of DPP-4 inhibitors, including vildagliptin over the past 25 years.
Baptist Gallwitz discusses the unmet need and recent developments in type 2 diabetes at ADA 2017. The filming of this interview was supported by AstraZeneca.
Baptist Gallwitz discusses the key findings from the EMPA-REG and CPD-Real studies for patients with type 2 diabetes. The filming of this interview was supported by AstraZeneca.
Silvio Inzucchi discusses the recent CV and renal data highlights from EMPA REG OUTCOME. The filming of this interview was supported by AstraZeneca.
Silvio Inzucchi shares his highlights from ADA 2017.
W David Strain and Päivi Maria Paldánius talk about the changing paradigms in the treatment and investigation into type 2 diabetes.
Chantal Mathieu discusses how the role of insulin therapy in diabetes is likely to change in coming years. Part 2 of 2 View Part 1 here.
Chantal Mathieu discusses the outcomes of the EMPA-REG, LEADER and SUSTAIN-6 trials on diabetes treatment. Part 1 of 2 View Part 2 here.
Nick Oliver, Wynn Professor of Metabolism Imperial College, London, UK discusses which presentations and/or data highlighted at the ADA 2017 interested him the most.
Prof Gallwitz discusses the unmet needs and latest developments in the treatment of type 2 diabetes.
Claudia Graham, Senior Vice President Dexcom Inc., San Diego, US discusses which presentations and data highlighted at the ADA 2017 interested her most.
ADA TV headed to the convention center floor to ask conference-goers why it’s so important to attend ADA’s Scientific Sessions. Published here with permission from American Diabetes Association.
BREAKING NEWS: Today we uncovered new research on how one class of diabetes medications alters the brain’s response to food—possibly reducing cravings and increasing satisfaction while eating. Rhonda Anderson reports from Boston. Published here with permission from American Diabetes Association.
BREAKING NEWS: Oral medications can help people with type 2 diabetes reach their blood glucose targets. But there has been a cloud of suspicion over new diabetes drugs and whether they may increase the risk for cardiovascular and other problems. Today we heard the results of studies that looked at...
BREAKING NEWS: Today the American Diabetes Association, the American Association of Diabetes Educators and the Academy of Nutrition and Dietetics released a joint statement that outlines when, how and what type of education and support people with diabetes should receive throughout their lifetime....